LBRX
LB PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$42.47
+0.78%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$42.22
From 52W high−14.17%
Volume516673.00
Market cap$1.37B
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataSep 18, 2026
Open
$42.22
From 52W high
−14.17%
Volume
516673.00
Market cap
$1.37B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−12.0x
P/E (TTM)
—
RSI (14)
37.6
MomentumView details →
1D Return
+0.78%
YTD Return
+86.87%
Similar companies
Latest newsMore news →
LB Pharmaceuticals Inc appointed Susan G. Kozauer, M.D. as Chief Medical Officer effective September 14, 2026.5d agoLB Pharmaceuticals Inc. appointed Joseph M. Miller as Chief Financial Officer, effective September 2, 2026, with an annual base salary of $530,000 and a target bonus of 40% of base salary.17d ago